DeutschNewstral
Article
bizjournals.com on 2015-06-12 20:35
Five things you don’t know about Jeff Jonas, CEO of Sage Therapeutics
Related news
Does Sage Therapeutics' Failure Predict Its Future Results?Forbes- Top former Alnylam exec Barry Greene named CEO of Sage Therapeuticsbizjournals.com
- Sage Therapeutics Takes Investors On A Wild Ride As CEO Talks Up Brain DrugsForbes
- New Drug Eases Postpartum Depression In Victory For Tiny Sage TherapeuticsForbes
- BSage Therapeutics Lays Off Staff to Save Cash After Failed Drug Trialbarrons.com
Sage Therapeutics surges on postpartum depression drug studyseattletimes.com- Sage Therapeutics sees modest results from tremor drug trialbizjournals.com
- Weed dispensary Sage Naturals changes name after lawsuit by Sage Therapeuticsbizjournals.com
- Sage Therapeutics CEO cashes in $35M worth of stock optionsbizjournals.com
- MSage Therapeutics stock bounces 49% after positive results for depression treatmentmarketwatch.com
- BSage Therapeutics Is Cratering Because Its Depression Treatment Failed In A Key Trialbarrons.com
- Promising drug by Sage Therapeutics helps treat post-partum depression in mid-stage trialbizjournals.com
- Sage Therapeutics to seek approval of postpartum depression drug after trial winbizjournals.com
- BSage Therapeutics Stock Collapsed Thursday. Analysts Say It Has Fallen Enough.barrons.com
- MSage Therapeutics shares surge 45% on positive trail of postpartum depression drugmarketwatch.com
- HJeff Sessions and Others: Don’t Quit!hamodia.com
- TJeff Sessions and others: Don’t quit!torontosun.com
FDA Approves Sage Therapeutics’ Zulressowsj.com